J. Goldman & Co’s iKang Healthcare Group, Inc. KANG Stock Holding History

J. Goldman & Co’s Portfolio KANG Stock Details KANG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-190,300	Closed	-$4.16M	–	443
2016 Q1	$4.16M	Buy	+190,300	New	+$3.96M	0.26%	107
2015 Q4	–	Sell	-114,568	Closed	-$1.7M	–	322
2015 Q3	$1.7M	Sell	114,568 -269,485	-70%	-$4.36M	0.15%	153
2015 Q2	$7.43M	Sell	384,053 -65,947	-15%	-$1.21M	0.45%	62
2015 Q1	$7.3M	Buy	450,000 +300,000	+200%	+$5M	0.45%	68
2014 Q4	$2.26M	Buy	+150,000	New	+$2.67M	0.27%	109
2014 Q3	–	Sell	-100,000	Closed	-$1.73M	–	365
2014 Q2	$1.73M	Buy	+100,000	New	+$1.5M	0.13%	158

Other funds holding KANG

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PRCM

Pine River Capital Management Minnetonka, Minnesota $32.9M AUM 4.47% 1-Year Est. Return

Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

ASI

All-Stars Investment Hong Kong $206M AUM 31.57% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

KCM

Keywise Capital Management Grand Cayman, Cayman Islands $220M AUM 21.27% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

GLG Partners London, United Kingdom $2.14B AUM 21.14% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

J. Goldman & Co's KANG Position: Q2 2016 in Review

J. Goldman & Co sold out of iKang Healthcare Group, Inc. (KANG) in Q2 2016, closing a stake of 190,300 shares — an estimated $4.16M sold.

J. Goldman & Co first reported a position in KANG in Q2 2014 and held it in 6 quarters. The position peaked at $7.43M in Q2 2015. 66 funds tracked by Wall St. Rank hold KANG as of Q2 2016.

J. Goldman & Co reported no remaining iKang Healthcare Group, Inc. position as of Q2 2016 after selling out during the quarter.
J. Goldman & Co sold 190,300 iKang Healthcare Group, Inc. shares in Q2 2016, an estimated $4.16M.
J. Goldman & Co first reported a position in iKang Healthcare Group, Inc. in Q2 2014 and held it in 6 quarters.
J. Goldman & Co's iKang Healthcare Group, Inc. position peaked at $7.43M in Q2 2015.
66 funds tracked by Wall St. Rank held iKang Healthcare Group, Inc. as of Q2 2016.

Based on J. Goldman & Co's 13F filing for Q2 2016, filed 15 Aug 2016.